Skip to main content
. 2021 Mar 17;2021(3):CD013732. doi: 10.1002/14651858.CD013732.pub2

Lago 1998.

Study characteristics
Methods Single‐centre randomised double‐blind controlled trial
Participants 55 preterm infants (26 to 34 weeks) requiring mechanical ventilation for hyaline membrane disease, with indwelling catheters
Exclusion criteria: asphyxia (Apgar < 5 at 5 minutes); foetal drug exposure; sepsis; major congenital anomalies
2 infants died (1 in fentanyl group and 1 in control group) and were excluded from analysis
Interventions Fentanyl group (n = 26): continuous infusion at 0.5 to 2 mcg/kg/hour adjusted to render the neonate sedated but arousable (according to the behavioural sedation score)
Control group (n = 27): no intervention
Outcomes Urine metanephrine:normetanephrine molar ratio concentration; behavioural sedation score (assessed every 2 hours during the study period); severity of hyaline membrane disease; need for surfactant replacement; evidence of clinically significant patent ductus arteriosus; days of ventilatory support and oxygen treatment; air leak; IVH; PVL; BPD; days to exclusive enteral feeding; days to reach birth weight; length of hospital stay
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Method of randomisation was not stated
Allocation concealment (selection bias) Low risk The use of sealed envelopes was reported (study author's communication)
Blinding of participants and personnel (performance bias) High risk Caregivers were not blinded
Blinding of outcome assessment (detection bias) Unclear risk Assessors were stated to be blinded to treatment, but blinding was unlikely
Incomplete outcome data (attrition bias) High risk 2 patients died after enrolment and were excluded from statistical analysis
Selective reporting (reporting bias) Unclear risk Trial not registered; protocol not available
Other bias Low risk Study appears to be free of other sources of bias